Lantheus Holdings, Inc. LNTH
101.01 USD +0.40 (+0.40%)
At closeNov 9, 2026, 4:00 PM EST
101.34 +0.33 +0.33%
After hours · Nov 9, 4:00 PM ET
100.61 Day range 101.11
50.16 52-week range 111.86
- YTD
- +51.78%
- 1 year
- +97.79%
News
benzinga.com PharmaLogic Holdings Agrees To Acquire Lantheus Holdings' CDMO Operations, Springfield Production Site; Financial Terms Not Disclosed PharmaLogic Holdings Corp. ("PharmaLogic" or the "Company"), the only independent contract development and manufacturing organization (CDMO) of scale dedicated exclusively to radiopharmaceuticals,…
benzinga.com Lantheus Holdings Q3 Adj. EPS $1.68 Beats $1.24 Estimate, Sales $389.913M Beat $359.757M Estimate Lantheus Holdings (NASDAQ:LNTH) reported quarterly earnings of $1.68 per share which beat the analyst consensus estimate of $1.24 by 35.48 percent. This is a 32.28 percent increase over earnings of…
globenewswire.com Lantheus Welcomes CMS CY27 Final Rule Advancing Access to Diagnostic Radiopharmaceuticals Final rule maintains separate payment for advanced diagnostic imaging agents and confirms PYLARIFY TruVu™ Transitional Pass-Through status through September 30, 2029; permanent HCPCS code A9613 now…
globenewswire.com Lantheus Reports Third Quarter 2026 Financial Results Worldwide revenue of $389.9 million in the third quarter of 2026 GAAP fully diluted earnings per share of $0.33, compared to $0.41 in the third quarter of 2025 Adjusted fully diluted earnings per…
benzinga.com This Adobe Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday Analysts downgraded ACGL, ASTS, PS, LNTH and ADBE, cutting ratings and price targets; ASTS target fell to $54 and Adobe’s to $267.
benzinga.com Mizuho Downgrades Lantheus Holdings to Neutral, Lowers Price Target to $109 Mizuho analyst Anthony Petrone downgrades Lantheus Holdings (NASDAQ:LNTH) from Outperform to Neutral and lowers the price target from $115 to $109.